| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LBRDA | Series C Common Stock | Options Exercise | $72.2M | +1.5M | +107.26% | $48.10 | 2.9M | Dec 16, 2024 | Direct | F1 |
| transaction | LBRDA | Series C Common Stock | Sale | -$5.86M | -71.5K | -2.47% | $82.00 | 2.83M | Dec 16, 2024 | Direct | F2 |
| transaction | LBRDA | Series C Common Stock | Tax liability | -$94.6M | -1.15M | -40.56% | $82.45 | 1.68M | Dec 16, 2024 | Direct | |
| transaction | LBRDA | Series C Common Stock | Sale | -$94.7K | -1.17K | -0.07% | $81.30 | 1.68M | Dec 17, 2024 | Direct | F3 |
| transaction | LBRDA | Series C Common Stock | Sale | -$9.58M | -119K | -7.08% | $80.60 | 1.56M | Dec 17, 2024 | Direct | F4 |
| holding | LBRDA | Series C Common Stock | 275K | Dec 16, 2024 | Maven 2016 - 1 GRAT | F5, F6 | |||||
| holding | LBRDA | Series C Common Stock | 138K | Dec 16, 2024 | Maven 2017 - 1 GRAT | F6, F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LBRDA | Stock Option - LBRDK (Right to Buy) | Options Exercise | $0 | -1.5M | -100% | $0.00 | 0 | Dec 16, 2024 | Series C Common Stock | 1.5M | $48.10 | Direct | F8 |
| Id | Content |
|---|---|
| F1 | Includes the distribution to the reporting person's direct holdings of 100 shares of the Issuer's Series C common stock on June 26, 2023, by the Maven 2017-1 GRAT; 160,962 shares of the Issuer's Series C common stock on February 29, 2024, by the Maven 2016-1 GRAT; and 118,320 shares of the Issuer's Series C common stock on June 26, 2024, by the Maven 2017-1 GRAT. |
| F2 | The price is a weighted average price. These shares were sold in multiple transactions ranging from $81.55 to $82.52, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission,the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F3 | The price is a weighted average price. These shares were sold in multiple transactions ranging from $81.235 to $81.415, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission,the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F4 | The price is a weighted average price. These shares were sold in multiple transactions ranging from $81.220 to $81.190, inclusive. The reporting person undertakes to provide to the Securities and Exchange Commission,the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F5 | Includes the distribution to the reporting person's direct holdings of 160,962 shares of the Issuer's Series C common stock on February 29,2024 by the Maven 2016-1 GRAT. |
| F6 | The reporting person is the sole trustee of the grantor retained annuity trust, for the benefit of himself, his spouse and his children. |
| F7 | Includes the distribution to the reporting person's direct holdings of (i) 100 shares of the Issuer's Series C common stock on June 26, 2023, by the Maven 2017-1 GRAT. and (ii) 118,320 shares of the Issuer's Series C common stock on June 26, 2024, by the Maven 2017-1 GRAT. |
| F8 | These options vested 50% on December 17, 2018, and 50% on December 17, 2019. |